期刊文献+

连苯三酚红法测定尿液及脑脊液蛋白的再认识 被引量:1

Pyrogallol Red Method for Determination of Urine and Cerebrospinal Fluid Protein and Know Again
下载PDF
导出
摘要 目的评估连苯三酚红法测定尿蛋白和脑脊液蛋白的分析性能。方法采用不精密度、回收率、空白限(LoB)、检出限(LoD)、功能灵敏度(FS)、分析测量范围(AMR)、临床可报告范围(CRR)进行评估;分析与磺基水杨酸定性法的关系。结果蛋白浓度在0.17~1.5g·L-1时,总变异系数(CV)<5%;平均回收率为98.6%;LoB、LoD和FS分别为0.01、0.02和0.04g·L-1;AMR为0.01~2.00g·L-1;CRR为0.04~40.0g·L-1。与磺基水杨酸定性结果比较显示:"-~+"的样本与定量结果无差异,"++~++++"的高值样本与定量结果有差异。结论连苯三酚红法的不精密度、回收率符合要求,建立的LoD、FS、最大稀释度和CRR可为临床提供更好的质量保证;但AMR比较窄,超出线性范围时,根据蛋白定性的结果决定待检标本是否需要进行预稀释处理。 Objective To evaluate the pyrogallol red method for the determination of urinary protein and cerebrospinal fluid protein. Methods The not precision, recovery rate, limit of blank (LOB), limit of detection (LoD), the functional sensitivity (FS), analytical measurement range (AMR) and clinical reportable range (CRR) were used to assess its performance; its relationship with the sulfosalicylic acid qualitative method was analyzed. Results When the protein concentration was 0.17-1.5 g·L^-1 , the total coefficient of variation (CV) was less than 5%, average recovery rate was 98.6%, and LoB, LoD, and FS were respectively 0.01, 0.02 and 0.04 g·L^-1. When AMR was 0.01-2.00 g·L^-1, the CRR was 0.04-40.0 g·L^-1 Compared with qualitative results of sulfosalicylic acid, there was no difference between "-~+" samples and quantitative results while differences were observed between "++~++++" high-value samples and quantitative results. Conclusion The imprecision and recovery rate of pyrogallol red method are in accordance with the requirements, and the established LoD, FS, the maximum dilution rate and CRR can offer better quality assurance for clinical application; however, as AMR is quite narrow, when out of linear range, whether specimens need treatment of pre-dilution are based on the protein qualitative results.
出处 《中国药事》 CAS 2012年第6期566-571,共6页 Chinese Pharmaceutical Affairs
关键词 连苯三酚红 磺基水杨酸 尿蛋白 脑脊液蛋白 全自动生化分析仪 pyrogallol red sulfosalicylic acid urine protein CSF protein automatic biochemical analyzer
  • 相关文献

参考文献4

二级参考文献12

  • 1秦晓光.“检查结果互认”和质量管理[J].中华检验医学杂志,2007,30(2):132-135. 被引量:45
  • 2李金明,申子瑜.正确认识临床实验室认可与提高检验质量之间的关系[J].中华检验医学杂志,2007,30(2):136-139. 被引量:38
  • 3毕波,吕元.定量检测方法学性能验证的系统设计[J].中华检验医学杂志,2007,30(2):143-145. 被引量:153
  • 4魏吴 丛玉隆.医学实验室质量管理与认可指南[M].北京:中国计量出版社,2004.72-75.
  • 5Department of Health and Human Services, Centers for Medicare & Medicaid Services. Clinical laboratory improvement amendments of 1988 : final rule. Fed Register, 2003:3704.
  • 6CLSI. EP15-A. User demonstration of performance for precision and accuracy ,2001 : 1-15.
  • 7CLSI. EP17-A, protocols for determination of limits of detection and limits of quantitation. 2004 : 1-39.
  • 8CLSI. EP 6-A2, evaluation of the linearity of quantative analytical methods. 2003 : 1-47.
  • 9CLSI. C28-A2, how to define and determine reference intervals in the clinical laboratory. 2000 : 1-31.
  • 10CLSI. EPS-A, evaluation of precision performance of clinical chemistry devices. 1999 : 1-28.

共引文献118

同被引文献10

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部